期刊文献+

267例子宫内膜癌的预后因素分析 被引量:3

Multivariate analysis of prognostic factors in 267 cases of endometrial carcinoma
下载PDF
导出
摘要 目的探讨影响子宫内膜癌患者生存及预后的因素。方法回顾性总结中山大学肿瘤医院妇科自2000年1月至2004年1月收治的经手术治疗的267例子宫内膜癌患者的临床病理资料和随访结果,进行生存分析及预后的影响因素分析。结果267例患者3年生存率、5年生存率分别为90.8%、88.1%,单因素分析显示:手术-病理分期、病理分级、组织学类型、肌层浸润深度、淋巴结转移、附件转移、术后是否治疗、ER和PR表达与预后有显著性相关(P<0.05)。经多因素分析后得出,手术-病理分期、病理分级、组织学类型、PR表达4个因素对子宫内膜癌患者的总生存率均产生显著性影响(P<0.05)。结论子宫内膜癌的5年生存率较高。手术-病理分期、病理分级、组织学类型、PR表达情况是影响预后的独立因素。 Objective To investigate the survival analysis of endometrialcarcinoma, and to explore its prognostic factors. Methods A total of 267 patients with endometrial carcinoma in our hospital from Jan. 2000 to Jan. 2004 were studied retrospectively. Prognostic factors were analyzed by univariate and multivariate analysis. Results The total 3 - year and 5 -year survival rate of 267 cases were 90.8% and 88.1%. The univariate analysis showed that operative stage, pathological type, histological grade, depth of muscularis invasion, lymph - node metastasis, adnexae metastasis, postoperation treatment, the expression of ER and PR significantly associated with the prognosis(P 〈 0. 05). However, on multivariate analysis, only operative stage, pathological type, histological grade and the expression of PR significantly correlated with 5 - year overall survival(P 〈 0.05 ). Conclusions The 5 - year survival rate of endometrial carcinoma is comparatively high. Operative stage, pathological type, histological grade and the expression of PR are independent prognostic factors of endometrial carcinoma.
出处 《医学信息(内.外科版)》 2009年第4期291-293,299,共4页 Medical Information Operations Sciences Fascicule
关键词 子宫内膜肿瘤 肿瘤分期 预后 因素分析 endometrial neoplasm tumor staging prognosis factors analysis
  • 相关文献

参考文献9

  • 1Ahmedin Jemal,Rebecca Siegel,Elizabeth Ward,et al.Cancer Statistics,2008[J].CA Cancer J Clin,2008,58:71 -96.
  • 2Sartori E,Laface B,Gaddueei A,et al.Factors influencing survival in endometial cancer relapsing patients:a Cooperation Task Force (CTF) study[J].Int J Gynecol Cancer,2003,13:458-465.
  • 3Morrow CP,Bundy BN,Kurman RJ,et al.Relationship between surgical-pathological risk of the endometrium:A gynecologic oncology group study[J].Gynecol Oncol,1991,40:55-65.
  • 4Alektiar KM,McKee A,Lin O,et al.The significance of the amount of myometrial invasion in patients with Stage I B endometrial carcinoma[J].Cancer,2002,95:316-321.
  • 5Kosary CL.FIGO stage,histology,histologic grade,age and race as prognostic factors in determining survival for caacers of the female gynexological system:Ananalysis of 1973-87 SEER cases of cancers of the endometrium,cervix,ovary,vulva,and vagina[J].Semin Surg Oncol,1994,10:31-46.
  • 6Steiner E,Eicher O,Sagemuller J,et al.Multivariate independent prognosic factors in endometrial carcinoma:a clinicopathologic study in 181 patients:10 years experience at the Department of Obstetrics and Gynecology of the Maniz University[J].Int J Gynecol Cancer,2003,13:197 -203.
  • 7吴鸣,沈铿,郎景和,黄荣丽,黄惠芳,潘凌亚,邓元琪.子宫内膜癌206例临床分析[J].中华妇产科杂志,2002,37(10):620-621. 被引量:43
  • 8Tabemero JM,Alonso MC,Ojeda B,et al.Endometrial cancer stages Ⅰ and Ⅱ.Analysis of survival and prognostic factors[J].Eur J Gynaecot Oncol,1995,16:18-25.
  • 9Ingram SS,Rosenman J,Heath R,et al.The predictive value of progesterone receptor levels in endometrial cancer[J].Int J Radiat Oncol Biol Phys,1989,17:21 -27.

二级参考文献6

  • 1Hendrickson M,Ross J,Eifel PJ,et al.Adenocarcinoma of the endometrium: analysis of 256 cases with carcinoma limited to the uterine corpus[].Gynecologic Oncology.1982
  • 2Hanson MB,van Nagell JR Jr,Powell DE,et al.The prognostic significance of lymph-vascular space invasion in stage Ⅰ endometrial cancer[].Cancer.1985
  • 3Takeshima N,Hirai Y,Tanaka N,et al.Pelvic lymph node metastasis in endometrial cancer with no myometrial invasion[].Obstetrics and Gynecology.1996
  • 4Morrow CP,Bundy BN,Kurman RJ,et al.Relationship between surgical-pathological risk factors and outcome in clinical stage Ⅰand Ⅱ carcinoma of the endometrium: a Gynecologic Oncology Group study[].Gynecologic Oncology.1991
  • 5Ambros RA,Kurman RJ.Combined assessment of vascular and myometrial invasion as a model to predict prognosis in stage Ⅰ endometrioid adenocarcinoma of the uterine corpus[].Cancer.1992
  • 6Lurain JR,Rice BL,Rademaker AW,et al.Prognostic factors associated with recurrence in clinical stage Ⅰ adenocarcinoma of the endometrium[].Obstetrics and Gynecology.1991

共引文献42

同被引文献19

  • 1Toh Y,Pencil SD,Nicolson GL.A novel candidate metastasis-asso-ciated-gene,mta1,differentially expressed in high metastatic mam-mary adenocarcinoma cell lines[J].J Biol Chem,1994,269(37):22958-222963.
  • 2Toh Y,Pencil SD,Nicolson GL.Analysis of the complete sequence of the novel candidate metastasis-associated gene,mta1,differentially expressed in highly metastatic mammary adenocarcinoma and breast cancer cell lines[J].Gene,1995,159(1):97-104.
  • 3Molli PR,Singh RR,Lee SW,et al.MTA1 mediated transcriptional repression of BRCA1 tumor suppressor gene[J].Oncogene,2008,27(14):1971-1980.
  • 4Mahoney MG,Simpson A,Jost M,et al.Metastasis associated protein (MTA1) 1 enhances migration,invasion and anchorage independent survival of immortalized human keratinocytes[J].Oncogene,2002,21(14):2161-2170.
  • 5Zhu X,Guo Y,Li X,et al.Metastasis-associated protein 1 nuclear expression is associated with tumor progression and clinical outcome in patients with non-small cell lung cancer[J].Thorac Oncol,2010,5(8):1159-1166.
  • 6Hofer M,Kuefer R,Varambally S,et al.The role of metastasis-as-sociated protein 1 in prostate cancer progression[J].Cancer Res,2004,64(3):825-829.
  • 7Hofer M,Chang MC,Hirko KA,et al.Immunohistochemical and clinicopathological correlation of the metastasis-associated gene 1 (MTA1) expression in benign and malignant pancreatic endocrine tumors[J].Mod Pathol,2009,22(7):933-939.
  • 8Murakami M,Kaul R,and Robertson E.MTA1 expression is linked to ovarian cancer[J].Cancer Biol Ther,2008,7(9):1468-1470.
  • 9Balasebthil S,Broaddus RR,Kumar R.Expression of metastasis-as-sociated protein1 (MTA1) in benign endometrium and endometrial adenocarcinomas[J].Hum Pathol,2006,37(6):656-661.
  • 10潘九林,韩素萍.子宫内膜癌中MTA1蛋白表达水平的研究[J].实用临床医药杂志,2007,11(6):32-34. 被引量:6

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部